Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union

Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU). A Steering Commi...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism Vol. 100; no. 4; p. 1245
Main Authors: Trasande, Leonardo, Zoeller, R Thomas, Hass, Ulla, Kortenkamp, Andreas, Grandjean, Philippe, Myers, John Peterson, DiGangi, Joseph, Bellanger, Martine, Hauser, Russ, Legler, Juliette, Skakkebaek, Niels E, Heindel, Jerrold J
Format: Journal Article
Language:English
Published: United States 01.04.2015
Subjects:
ISSN:1945-7197, 1945-7197
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU). A Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data. Expert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs. EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.
AbstractList Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.CONTEXTRapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU).OBJECTIVEThe objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU).A Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data.DESIGNA Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data.Expert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs.RESULTSExpert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs.EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.CONCLUSIONSEDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.
Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU). A Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data. Expert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs. EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.
Author Hauser, Russ
Hass, Ulla
Zoeller, R Thomas
Kortenkamp, Andreas
Skakkebaek, Niels E
Trasande, Leonardo
Bellanger, Martine
DiGangi, Joseph
Legler, Juliette
Grandjean, Philippe
Myers, John Peterson
Heindel, Jerrold J
Author_xml – sequence: 1
  givenname: Leonardo
  surname: Trasande
  fullname: Trasande, Leonardo
  organization: New York University (NYU) School of Medicine (L.T.), New York, New York 10016; NYU Wagner School of Public Service (L.T.), New York, New York 10012; NYU Steinhardt School of Culture, Education, and Human Development (L.T.), Department of Nutrition, Food & Public Health, New York, New York 10003; NYU Global Institute of Public Health (L.T.), New York, New York 10003; University of Massachusetts (R.T.Z.), Amherst, Massachusetts 01003; National Food Institute (U.H.), Technical University of Denmark, 19 2860 Søborg, Denmark; Brunel University (A.K., R.H.), Institute of Environment, Health and Societies, Uxbridge, Middlesex UB8 3PH, United Kingdom; Department of Environmental Health (P.G.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115; University of Southern Denmark (P.G.), 5000 Odense, Denmark; Environmental Health Sciences (J.P.M.), Charlottesville, Virginia 22902; IPEN (J.D.), SE-402 35 Gothenburg, Sweden; EHESP School of Public Health (M.B.), 75014 Paris, France; Department of Chemistry and Biology (J.L.), Institute for Environmental Studies, VU University, 1081 HV Amsterdam, The Netherlands; Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Endocrine Disruption of Male Reproduction and Child Health (EDMaRC) and University of Copenhagen, DK-2100 Copenhagen, Denmark; and National Institute of Environmental Health Sciences (J.J.H.), Division of Extramural Research and Training, Research Triangle Park, North Carolina 27709
– sequence: 2
  givenname: R Thomas
  surname: Zoeller
  fullname: Zoeller, R Thomas
– sequence: 3
  givenname: Ulla
  surname: Hass
  fullname: Hass, Ulla
– sequence: 4
  givenname: Andreas
  surname: Kortenkamp
  fullname: Kortenkamp, Andreas
– sequence: 5
  givenname: Philippe
  surname: Grandjean
  fullname: Grandjean, Philippe
– sequence: 6
  givenname: John Peterson
  surname: Myers
  fullname: Myers, John Peterson
– sequence: 7
  givenname: Joseph
  surname: DiGangi
  fullname: DiGangi, Joseph
– sequence: 8
  givenname: Martine
  surname: Bellanger
  fullname: Bellanger, Martine
– sequence: 9
  givenname: Russ
  surname: Hauser
  fullname: Hauser, Russ
– sequence: 10
  givenname: Juliette
  surname: Legler
  fullname: Legler, Juliette
– sequence: 11
  givenname: Niels E
  surname: Skakkebaek
  fullname: Skakkebaek, Niels E
– sequence: 12
  givenname: Jerrold J
  surname: Heindel
  fullname: Heindel, Jerrold J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25742516$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtLxDAURoOMOA_duZYs3XRs0qRpljKMDxhwo-uSpjczGaZJTRrQf2_wAa7uhXvuB99ZopnzDhC6JuWaUFLeHfWaloQVrKLsDC2IZLwQRIrZv32OljEey4wxXl2gOeWCUU7qBdpv42QHNVm3x10KPTisXI97G0FFwNrHKWJvMHyMPqYAePIYXO91sA6KjIU0fj_rAwxWq1PE1uHpAHibgh9BOZyc9e4SnZt8hKvfuUJvD9vXzVOxe3l83tzvCs2bpimkJmVnOg5MKGVETQ3pDJVAJOjcD8CwuqJQMS5MA8ooQzTUIKQSjAhO6Ard_uSOwb8niFM72KjhdFIOfIotqUW2VktRZvTmF03dAH07hiwifLZ_cugXsvppig
CitedBy_id crossref_primary_10_1016_j_jenvman_2024_122108
crossref_primary_10_1080_19338244_2018_1535480
crossref_primary_10_1016_j_scitotenv_2018_03_003
crossref_primary_10_1016_j_cotox_2019_10_006
crossref_primary_10_1038_s41574_025_01098_9
crossref_primary_10_1186_s12940_019_0454_x
crossref_primary_10_1289_EHP1774
crossref_primary_10_1016_j_aquatox_2022_106095
crossref_primary_10_1038_pr_2017_168
crossref_primary_10_1210_jendso_bvae083
crossref_primary_10_1007_s41745_022_00319_8
crossref_primary_10_1016_j_ijheh_2023_114311
crossref_primary_10_1016_S2213_8587_20_30128_5
crossref_primary_10_1074_jbc_RA119_011138
crossref_primary_10_3390_ijerph14101158
crossref_primary_10_1016_j_envres_2024_119836
crossref_primary_10_1016_j_envint_2025_109518
crossref_primary_10_1016_j_etap_2016_09_010
crossref_primary_10_3390_ijms22052540
crossref_primary_10_1002_mrd_23116
crossref_primary_10_1016_j_chemosphere_2017_10_084
crossref_primary_10_1016_j_scp_2015_08_001
crossref_primary_10_3390_toxics12080541
crossref_primary_10_1186_s12940_023_01039_x
crossref_primary_10_1210_en_2018_00056
crossref_primary_10_1016_j_envint_2018_02_029
crossref_primary_10_3389_fped_2021_705395
crossref_primary_10_1289_EHP378
crossref_primary_10_3389_fendo_2019_00033
crossref_primary_10_1080_00036846_2018_1494803
crossref_primary_10_1016_j_scitotenv_2019_01_255
crossref_primary_10_1016_j_scitotenv_2020_144517
crossref_primary_10_1016_j_envres_2022_113609
crossref_primary_10_1016_j_jhazmat_2024_136506
crossref_primary_10_1007_s11154_016_9334_7
crossref_primary_10_1007_s00204_017_1985_y
crossref_primary_10_1038_s41574_023_00872_x
crossref_primary_10_1016_j_ijheh_2016_05_001
crossref_primary_10_1016_j_chemosphere_2022_136333
crossref_primary_10_1155_2016_8765049
crossref_primary_10_3390_toxics11020121
crossref_primary_10_1002_etc_3486
crossref_primary_10_1097_GCO_0000000000000722
crossref_primary_10_3390_su11174785
crossref_primary_10_1093_humrep_dev292
crossref_primary_10_1016_j_scitotenv_2020_136570
crossref_primary_10_1016_j_envint_2016_01_021
crossref_primary_10_3390_ijerph182413047
crossref_primary_10_1016_j_jclinepi_2018_11_024
crossref_primary_10_1016_S2213_8587_16_30275_3
crossref_primary_10_1007_s00429_020_02089_4
crossref_primary_10_1093_humrep_dead230
crossref_primary_10_1016_j_jes_2017_10_013
crossref_primary_10_1089_thy_2018_0417
crossref_primary_10_1002_jbmr_2879
crossref_primary_10_1186_s12302_018_0139_z
crossref_primary_10_1186_s12302_020_00446_y
crossref_primary_10_1016_j_ijgo_2015_09_002
crossref_primary_10_1002_gch2_202300198
crossref_primary_10_1016_j_chemosphere_2017_02_146
crossref_primary_10_1016_j_jhazmat_2025_138946
crossref_primary_10_1016_j_cbi_2019_04_013
crossref_primary_10_1016_S2468_2020_16_30056_0
crossref_primary_10_1136_jech_2016_208006
crossref_primary_10_1016_j_mce_2019_110666
crossref_primary_10_1080_10408398_2019_1611539
crossref_primary_10_1186_s12302_024_00999_2
crossref_primary_10_15252_embr_201744294
crossref_primary_10_1002_admi_201902100
crossref_primary_10_1016_j_ajog_2016_01_182
crossref_primary_10_1016_j_jhazmat_2017_03_036
crossref_primary_10_2174_0929867324666170518095736
crossref_primary_10_1016_j_chemosphere_2024_142601
crossref_primary_10_1016_j_envint_2016_10_018
crossref_primary_10_3389_fgene_2020_00405
crossref_primary_10_1159_000443400
crossref_primary_10_1289_EHP10273
crossref_primary_10_3389_fmed_2025_1583203
crossref_primary_10_1136_jech_2016_207841
crossref_primary_10_3389_ftox_2022_909307
crossref_primary_10_1155_2018_6821601
crossref_primary_10_1210_en_2017_00348
crossref_primary_10_1093_toxsci_kfx133
crossref_primary_10_1007_s12595_021_00410_5
crossref_primary_10_1016_S2213_8587_21_00052_8
crossref_primary_10_1007_s11154_016_9329_4
crossref_primary_10_1186_s12940_017_0265_x
crossref_primary_10_1016_j_envpol_2022_119918
crossref_primary_10_1016_j_envint_2021_106574
crossref_primary_10_1016_j_tox_2022_153255
crossref_primary_10_1210_en_2016_1342
crossref_primary_10_1016_j_totert_2023_100071
crossref_primary_10_1016_S2213_8587_16_30121_8
crossref_primary_10_1038_nrendo_2016_198
crossref_primary_10_1016_S2213_8587_20_30129_7
crossref_primary_10_1177_2053019619872808
crossref_primary_10_1136_jech_2016_208463
crossref_primary_10_1016_j_jhazmat_2020_122929
crossref_primary_10_3390_ijms21082988
crossref_primary_10_1016_j_jhazmat_2020_122020
crossref_primary_10_1186_s12302_022_00670_8
crossref_primary_10_1016_j_ecoenv_2022_113826
crossref_primary_10_1016_j_cbi_2022_109952
crossref_primary_10_1017_S0963180117000111
crossref_primary_10_1210_jc_2015_1622
crossref_primary_10_1055_a_1533_2861
crossref_primary_10_1016_j_hazadv_2022_100107
crossref_primary_10_1210_jendso_bvad141
crossref_primary_10_1186_s12940_017_0340_3
crossref_primary_10_3390_ijerph13020181
crossref_primary_10_1111_jjns_12347
crossref_primary_10_1016_j_jhazmat_2021_127327
crossref_primary_10_1111_ina_13030
crossref_primary_10_1111_joim_13748
crossref_primary_10_1016_j_ecoenv_2019_109406
crossref_primary_10_1007_s00204_019_02641_0
crossref_primary_10_1016_j_envres_2021_112415
crossref_primary_10_1016_j_neuro_2025_04_001
crossref_primary_10_1111_andr_12178
crossref_primary_10_1038_s41598_017_02885_9
crossref_primary_10_1016_j_neuint_2016_06_003
crossref_primary_10_1016_j_cbi_2017_03_001
crossref_primary_10_1038_nprot_2016_068
crossref_primary_10_3390_ijerph16061084
crossref_primary_10_1088_1755_1315_1013_1_012014
crossref_primary_10_1159_000446436
crossref_primary_10_1016_j_freeradbiomed_2022_09_024
crossref_primary_10_1289_EHP644
crossref_primary_10_3390_ijms24043296
crossref_primary_10_1038_srep42907
crossref_primary_10_3390_toxics10040181
crossref_primary_10_1038_536030d
crossref_primary_10_1016_j_jhealeco_2020_102341
crossref_primary_10_1007_s11356_018_3774_4
crossref_primary_10_1016_j_tox_2017_05_004
crossref_primary_10_1093_ajcn_nqab308
crossref_primary_10_1289_EHP6047
crossref_primary_10_1007_s11154_016_9327_6
crossref_primary_10_1016_j_envpol_2017_03_021
crossref_primary_10_3390_ijms18091909
crossref_primary_10_1016_j_watres_2025_124301
crossref_primary_10_1016_j_envint_2019_02_025
crossref_primary_10_1080_10934529_2018_1530539
crossref_primary_10_1007_s10646_016_1612_3
crossref_primary_10_3917_rpre_214_0119
crossref_primary_10_1016_j_scitotenv_2019_03_258
crossref_primary_10_1016_j_jclepro_2021_126701
crossref_primary_10_1002_2017GH000119
crossref_primary_10_1177_2053019617726308
crossref_primary_10_1016_j_envint_2021_106547
crossref_primary_10_3390_su11164344
crossref_primary_10_1016_j_marenvres_2025_107143
crossref_primary_10_1021_envhealth_4c00277
crossref_primary_10_1007_s00204_017_2014_x
crossref_primary_10_1016_j_ijheh_2024_114422
crossref_primary_10_1371_journal_pone_0145368
crossref_primary_10_3390_bios11020046
crossref_primary_10_3390_ijms21082954
crossref_primary_10_1016_S2213_8587_16_30279_0
crossref_primary_10_1093_eurpub_ckaa074
crossref_primary_10_1016_j_scitotenv_2021_150887
crossref_primary_10_1016_S2213_8587_15_00423_4
crossref_primary_10_1097_GCO_0000000000000373
crossref_primary_10_3389_ftox_2021_649024
crossref_primary_10_1016_j_watres_2024_122543
crossref_primary_10_1097_EDE_0000000000000525
crossref_primary_10_1016_j_mce_2020_110711
crossref_primary_10_3390_toxics10120766
crossref_primary_10_1016_j_watres_2023_120645
crossref_primary_10_1016_j_ecoenv_2024_116838
crossref_primary_10_1289_ehp_1510810
crossref_primary_10_3390_ijms26188979
crossref_primary_10_3390_w15030582
crossref_primary_10_1016_j_toxlet_2019_05_006
crossref_primary_10_1016_j_scr_2017_10_013
crossref_primary_10_1016_j_ecoenv_2019_04_045
crossref_primary_10_1016_j_envsci_2024_103694
crossref_primary_10_1289_ehp_1409535
crossref_primary_10_3390_agronomy11122494
crossref_primary_10_1007_s10661_015_4754_5
crossref_primary_10_1093_scipol_scx004
crossref_primary_10_1016_j_crvi_2017_07_006
crossref_primary_10_1186_s12940_020_00635_5
crossref_primary_10_1016_j_crvi_2017_07_008
crossref_primary_10_1016_j_scitotenv_2019_06_300
crossref_primary_10_1016_j_pmr_2022_04_010
crossref_primary_10_1007_s11356_019_05340_6
crossref_primary_10_1016_j_jclinepi_2019_03_009
crossref_primary_10_1016_j_reprotox_2016_10_001
crossref_primary_10_1016_j_scitotenv_2019_133921
crossref_primary_10_1177_1048291116666485
crossref_primary_10_3390_ijerph191610458
crossref_primary_10_1016_j_ebiom_2020_102640
crossref_primary_10_1093_aje_kwx267
crossref_primary_10_1016_j_envint_2018_12_032
crossref_primary_10_1016_j_tifs_2018_11_029
crossref_primary_10_1186_s12940_022_00858_8
crossref_primary_10_1016_j_envres_2023_115788
crossref_primary_10_3390_toxics10030146
crossref_primary_10_1038_s41591_025_03697_5
crossref_primary_10_1007_s11270_025_08343_x
crossref_primary_10_1073_pnas_2412714121
crossref_primary_10_1016_j_neuint_2016_10_011
crossref_primary_10_1146_annurev_publhealth_071823_105338
crossref_primary_10_1007_s11356_015_5162_7
crossref_primary_10_3389_fendo_2024_1401120
crossref_primary_10_1289_EHP217
crossref_primary_10_1007_s00216_019_01805_2
crossref_primary_10_1016_S2213_8587_17_30316_9
crossref_primary_10_3390_w13101347
crossref_primary_10_1016_j_neubiorev_2025_106028
crossref_primary_10_1016_j_banm_2024_03_004
crossref_primary_10_1016_j_jhazmat_2018_03_032
crossref_primary_10_1016_j_envres_2025_120828
crossref_primary_10_1146_annurev_pharmtox_021921_093352
crossref_primary_10_1360_CSB_2025_0225
crossref_primary_10_1016_j_talanta_2024_125665
crossref_primary_10_1159_000504668
crossref_primary_10_1016_j_ijheh_2025_114647
crossref_primary_10_1007_s12103_016_9362_6
crossref_primary_10_1016_j_envpol_2021_118021
crossref_primary_10_1016_j_etap_2016_10_015
crossref_primary_10_1007_s11356_023_31384_w
crossref_primary_10_1186_s12940_016_0156_6
crossref_primary_10_1016_j_envint_2023_108161
crossref_primary_10_3390_jox11040012
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1210/jc.2014-4324
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
ExternalDocumentID 25742516
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
3O-
4.4
48X
53G
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAPGJ
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABBLC
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABUWG
ABVGC
ABWST
ABXVV
ABXZS
ACFRR
ACGFO
ACGFS
ACPRK
ACUTJ
ACVCV
ACYHN
ACZBC
ADBBV
ADGKP
ADGZP
ADHKW
ADMTO
ADNBA
ADQBN
ADRTK
ADVEK
ADZCM
AELWJ
AEMDU
AEMQT
AENEX
AENZO
AEOTA
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFQV
AFFZL
AFGWE
AFKRA
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGORE
AGQXC
AGUTN
AHGBF
AHMBA
AHMMS
AI.
AJBYB
AJDVS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALXQX
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ASPBG
ATGXG
AVNTJ
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CCPQU
CDBKE
CGR
CS3
CUY
CVF
D-I
DAKXR
DIK
E3Z
EBS
ECM
EIF
EIHJH
EJD
EMOBN
ENERS
F5P
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
GX1
H13
HMCUK
HVGLF
HZ~
H~9
IAO
IHR
INH
ITC
J5H
KBUDW
KOP
KSI
KSN
L7B
M1P
M5~
MBLQV
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NPM
NU-
NVLIB
O9-
OAUYM
OBFPC
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
REU
ROX
ROZ
TEORI
TJX
TLC
TMA
TR2
TWZ
UKHRP
VH1
VVN
W8F
WHG
WOQ
X52
X7M
YBU
YFH
YHG
YOC
YSK
ZGI
ZXP
ZY1
~02
~H1
7X8
AEHZK
ID FETCH-LOGICAL-c5888-9c10bfb5e47aaf762f1bf29e19ec324eef4632e3457f8eafaf1ce6e79a7417512
IEDL.DBID 7X8
ISICitedReferencesCount 257
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00004678-201504000-00008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1945-7197
IngestDate Thu Oct 02 15:42:23 EDT 2025
Mon Jul 21 05:58:48 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5888-9c10bfb5e47aaf762f1bf29e19ec324eef4632e3457f8eafaf1ce6e79a7417512
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-83769
PMID 25742516
PQID 1671216970
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1671216970
pubmed_primary_25742516
PublicationCentury 2000
PublicationDate 2015-April
PublicationDateYYYYMMDD 2015-04-01
PublicationDate_xml – month: 04
  year: 2015
  text: 2015-April
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2015
References 19433249 - Mol Cell Endocrinol. 2009 May 25;304(1-2):63-8
6942722 - Ann N Y Acad Sci. 1981;363:189-204
18665197 - J Expo Sci Environ Epidemiol. 2009 Feb;19(2):223-34
10984369 - J Allergy Clin Immunol. 2000 Sep;106(3):493-9
18613034 - Birth Defects Res B Dev Reprod Toxicol. 2008 Jun;83(3):157-395
10929856 - Med Decis Making. 2000 Jul-Sep;20(3):332-42
3102916 - Milbank Q. 1986;64(4):489-547
18941581 - Environ Health Perspect. 2008 Oct;116(10):1376-82
14283879 - Proc R Soc Med. 1965 May;58:295-300
20562054 - Environ Health Perspect. 2010 Oct;118(10):1444-9
12777573 - Pediatrics. 2003 Jun;111(6 Pt 1):1467-74
10548101 - Nature. 1999 Oct 21;401(6755):763-4
17105985 - J Natl Cancer Inst. 2006 Nov 15;98(22):1623-33
23963708 - Obesity (Silver Spring). 2014 Feb;22(2):488-96
11413183 - J Epidemiol Community Health. 2001 Jul;55(7):508-14
15840436 - Toxicology. 2005 Jun 1;210(2-3):223-33
8849754 - JAMA. 1996 Oct 16;276(15):1253-8
25742518 - J Clin Endocrinol Metab. 2015 Apr;100(4):1278-88
11294977 - Toxicol Sci. 2001 May;61(1):76-82
21676388 - Environ Res. 2011 Aug;111(6):825-30
12088877 - Mol Cell Endocrinol. 2002 Jun 28;192(1-2):157-70
19433246 - Mol Cell Endocrinol. 2009 May 25;304(1-2):43-8
17119266 - Ann N Y Acad Sci. 2006 Sep;1076:911-23
21259266 - Mt Sinai J Med. 2011 Jan-Feb;78(1):98-106
11836195 - Am J Epidemiol. 2002 Feb 15;155(4):313-22
18619930 - Econ Hum Biol. 2008 Jul;6(2):281-92
15205295 - BMJ. 2004 Jun 19;328(7454):1490
6923138 - Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429-62
18483053 - BMJ. 2008 May 17;336(7653):1106-10
21924589 - Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79
15498886 - Endocrinology. 2005 Feb;146(2):607-12
20403173 - BMC Health Serv Res. 2010 Apr 19;10:97
15615589 - BMC Health Serv Res. 2004 Dec 22;4(1):38
22147869 - Health Aff (Millwood). 2011 Dec;30(12):2400-9
3082226 - Am J Public Health. 1986 Apr;76(4):392-6
25454231 - Environ Int. 2015 Jan;74:144-51
12356922 - Occup Environ Med. 2002 Oct;59(10):651-2
1434963 - Med Care. 1992 Nov;30(11 Suppl):NS1-12
21478780 - Med Care. 2011 Aug;49(8):679-85
16804814 - Semin Reprod Med. 2006 Jul;24(3):156-67
9019804 - Science. 1997 Jan 24;275(5299):463
15198913 - Environ Health Perspect. 2004 Jun;112(9):944-9
25742517 - J Clin Endocrinol Metab. 2015 Apr;100(4):1267-77
25742515 - J Clin Endocrinol Metab. 2015 Apr;100(4):1256-66
24177261 - Toxicol Lett. 2013 Dec 16;223(3):295-305
10468437 - Epidemiology. 1999 Sep;10(5):573-84
17938728 - Environ Health Perspect. 2007 Oct;115(10):1406-14
22733974 - Endocrinology. 2012 Sep;153(9):4097-110
8922972 - Health Econ. 1996 Sep-Oct;5(5):447-67
23473920 - Environ Res. 2013 May;123:17-24
21543421 - Health Aff (Millwood). 2011 May;30(5):863-70
22990270 - JAMA. 2012 Sep 19;308(11):1113-21
References_xml – reference: 15205295 - BMJ. 2004 Jun 19;328(7454):1490
– reference: 19433249 - Mol Cell Endocrinol. 2009 May 25;304(1-2):63-8
– reference: 21259266 - Mt Sinai J Med. 2011 Jan-Feb;78(1):98-106
– reference: 8922972 - Health Econ. 1996 Sep-Oct;5(5):447-67
– reference: 3082226 - Am J Public Health. 1986 Apr;76(4):392-6
– reference: 15615589 - BMC Health Serv Res. 2004 Dec 22;4(1):38
– reference: 23963708 - Obesity (Silver Spring). 2014 Feb;22(2):488-96
– reference: 22147869 - Health Aff (Millwood). 2011 Dec;30(12):2400-9
– reference: 6923138 - Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429-62
– reference: 15198913 - Environ Health Perspect. 2004 Jun;112(9):944-9
– reference: 11836195 - Am J Epidemiol. 2002 Feb 15;155(4):313-22
– reference: 22990270 - JAMA. 2012 Sep 19;308(11):1113-21
– reference: 8849754 - JAMA. 1996 Oct 16;276(15):1253-8
– reference: 16804814 - Semin Reprod Med. 2006 Jul;24(3):156-67
– reference: 10984369 - J Allergy Clin Immunol. 2000 Sep;106(3):493-9
– reference: 24177261 - Toxicol Lett. 2013 Dec 16;223(3):295-305
– reference: 25742515 - J Clin Endocrinol Metab. 2015 Apr;100(4):1256-66
– reference: 25742517 - J Clin Endocrinol Metab. 2015 Apr;100(4):1267-77
– reference: 25742518 - J Clin Endocrinol Metab. 2015 Apr;100(4):1278-88
– reference: 10548101 - Nature. 1999 Oct 21;401(6755):763-4
– reference: 9019804 - Science. 1997 Jan 24;275(5299):463
– reference: 17119266 - Ann N Y Acad Sci. 2006 Sep;1076:911-23
– reference: 21478780 - Med Care. 2011 Aug;49(8):679-85
– reference: 3102916 - Milbank Q. 1986;64(4):489-547
– reference: 18941581 - Environ Health Perspect. 2008 Oct;116(10):1376-82
– reference: 20403173 - BMC Health Serv Res. 2010 Apr 19;10:97
– reference: 17938728 - Environ Health Perspect. 2007 Oct;115(10):1406-14
– reference: 17105985 - J Natl Cancer Inst. 2006 Nov 15;98(22):1623-33
– reference: 21924589 - Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79
– reference: 18483053 - BMJ. 2008 May 17;336(7653):1106-10
– reference: 20562054 - Environ Health Perspect. 2010 Oct;118(10):1444-9
– reference: 15840436 - Toxicology. 2005 Jun 1;210(2-3):223-33
– reference: 12088877 - Mol Cell Endocrinol. 2002 Jun 28;192(1-2):157-70
– reference: 21676388 - Environ Res. 2011 Aug;111(6):825-30
– reference: 12356922 - Occup Environ Med. 2002 Oct;59(10):651-2
– reference: 12777573 - Pediatrics. 2003 Jun;111(6 Pt 1):1467-74
– reference: 22733974 - Endocrinology. 2012 Sep;153(9):4097-110
– reference: 1434963 - Med Care. 1992 Nov;30(11 Suppl):NS1-12
– reference: 6942722 - Ann N Y Acad Sci. 1981;363:189-204
– reference: 11294977 - Toxicol Sci. 2001 May;61(1):76-82
– reference: 14283879 - Proc R Soc Med. 1965 May;58:295-300
– reference: 19433246 - Mol Cell Endocrinol. 2009 May 25;304(1-2):43-8
– reference: 25454231 - Environ Int. 2015 Jan;74:144-51
– reference: 18619930 - Econ Hum Biol. 2008 Jul;6(2):281-92
– reference: 23473920 - Environ Res. 2013 May;123:17-24
– reference: 11413183 - J Epidemiol Community Health. 2001 Jul;55(7):508-14
– reference: 10468437 - Epidemiology. 1999 Sep;10(5):573-84
– reference: 15498886 - Endocrinology. 2005 Feb;146(2):607-12
– reference: 18613034 - Birth Defects Res B Dev Reprod Toxicol. 2008 Jun;83(3):157-395
– reference: 10929856 - Med Decis Making. 2000 Jul-Sep;20(3):332-42
– reference: 21543421 - Health Aff (Millwood). 2011 May;30(5):863-70
– reference: 18665197 - J Expo Sci Environ Epidemiol. 2009 Feb;19(2):223-34
SSID ssj0014453
Score 2.6002808
Snippet Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. The objective was to...
Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.CONTEXTRapidly...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1245
SubjectTerms Adult
Aged
Attention Deficit Disorder with Hyperactivity - chemically induced
Attention Deficit Disorder with Hyperactivity - economics
Attention Deficit Disorder with Hyperactivity - epidemiology
Autistic Disorder - chemically induced
Autistic Disorder - economics
Autistic Disorder - epidemiology
Child
Cost of Illness
Endocrine Disruptors - toxicity
Endocrine System Diseases - economics
Endocrine System Diseases - epidemiology
Environmental Exposure - economics
Environmental Exposure - statistics & numerical data
Environmental Pollutants - toxicity
European Union - economics
European Union - statistics & numerical data
Female
Humans
Male
Middle Aged
Title Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union
URI https://www.ncbi.nlm.nih.gov/pubmed/25742516
https://www.proquest.com/docview/1671216970
Volume 100
WOSCitedRecordID wos00004678-201504000-00008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-1FeMhKrRZyX4wkh1IqBVh0AdYsc51zB4ATSIn4-58RVJyQklkyxbN2dz9-9CblJIUxKqfF-60KwuBARkwaVocLHvwwzrWU7DOb1SYzH2XQqJ97h1vi0yqVObBV1WWnnI7_lqeAhT6UI7uoP5qZGueiqH6GxTnoRQhkn1WK6iiLEcduFEu30hAkuhU98d1Ur7659IY-Za0j3O7hsH5nh7n-Pt0d2PLyk95087JM1sAdka-QD6IdkNsAr7UCqndGirWCgypbUh2morpp5QytD4buunO-QzisKFrd3RYIMf_tc1O1i7RsNNPTNUgSRdOnWpwuLrD4iL8PB88Mj87MWmE7QCGZS86AwRQKxUMqghjS8MKEELkEjiQBMnEYhRHEiTAbKKMM1pCCkQkgiEDUckw1bWTglVCrNo6wIlAhKtN6kigH3EDoMHNYMsj65XpIwR1l2AQploVo0-YqIfXLS8SGvu6YbOaoWVC88PfvD6nOyjcxNugSbC9IzSA24JJv6a450umqFBL_jyegHusPH1A
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimating+burden+and+disease+costs+of+exposure+to+endocrine-disrupting+chemicals+in+the+European+union&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Trasande%2C+Leonardo&rft.au=Zoeller%2C+R+Thomas&rft.au=Hass%2C+Ulla&rft.au=Kortenkamp%2C+Andreas&rft.date=2015-04-01&rft.issn=1945-7197&rft.eissn=1945-7197&rft.volume=100&rft.issue=4&rft.spage=1245&rft_id=info:doi/10.1210%2Fjc.2014-4324&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1945-7197&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1945-7197&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1945-7197&client=summon